文献速递治疗药物监测与药物基因组学特殊人群用药

目标控制输注用于抗生素给药:万古霉素在ICU患者中的计算机模拟原理验证

Target-Controlled Continuous Infusion for Antibiotic Dosing: Proof-of-Principle in an In-silico Vancomycin Trial in Intensive Care Unit Patients.
PubMed 文献 · Clin Pharmacokinet · 2018-01-01

本研究为计算机模拟试验,以万古霉素为模型药物,在ICU患者中比较目标控制输注(TCI)、自适应目标控制输注(aTCI,结合治疗药物监测数据)与常规基于TDM的给药策略。结果显示aTCI在达标概率上优于基于规则的给药指南,且高浓度暴露风险低,在不同亚组中表现一致。

要点

  • aTCI在48小时内达标概率显著高于次优方法Cristallini。
  • aTCI在最初数小时内浓度超过30 mg·L⁻¹的风险可忽略,概率不超过25%。
  • TCI性能在人群各亚组中保持一致,而其他方法不一致。

核心结论

  • 自适应目标控制输注有潜力成为ICU中患者个体化抗生素给药的实用工具。

研究设计与样本

  • 计算机模拟临床试验,基于ICU患者临床记录数据库和万古霉素群体药代动力学模型的系统综述。

主要发现

  • 治疗24和48小时后,aTCI与Cristallini方法的达标概率分别为54%和72%以及47%和59%。
  • Cristallini方法在治疗最初数小时达到浓度>30 mg·L⁻¹的概率>65%,而aTCI该概率不超过25%且风险时间可忽略。
  • TCI的性能在人群各亚组中一致,其他方法则不然。

临床怎么用

  • 在ICU中可考虑使用自适应目标控制输注实施万古霉素个体化给药,以提升早期达标概率并降低高浓度暴露风险。

局限性

  • 本研究为计算机模拟研究,结论需临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: In this in-silico study, we investigate the clinical utility of target-controlled infusion for antibiotic dosing in an intensive care unit setting using vancomycin as a model compound. We compared target-controlled infusion and adaptive target-controlled infusion, which combines target-controlled infusion with data from therapeutic drug monitoring, with conventional (therapeutic drug monitoring-based) vancomycin dosing strategies. METHODS: A clinical trial simulation was conducted. This simulation was based on a comprehensive database of clinical records of intensive care unit patients and a systematic review of currently available population-pharmacokinetic models for vancomycin in intensive care unit patients. Dosing strategies were compared in terms of the probability of achieving efficacious concentrations as well as the potential for inducing toxicity. RESULTS: Adaptive target-controlled infusion outperforms rule-based dosing guidelines for vancomycin. In the first 48 h of treatment, the probability of target attainment is significantly higher for adaptive target-controlled infusion than for the second-best method (Cristallini). Probability of target attainments of 54 and 72% and 47 and 59% for both methods after 24 and 48 h, respectively. Compared to the Cristallini method, which is characterized by a probability of attaining concentrations above 30 mg.L-1 > 65% in the first few hours of treatment, adaptive target-controlled infusion shows negligible time at risk and a probability of attaining concentrations above 30 mg.L-1 not exceeding 25%. Finally, in contrast to the other methods, the performance of target-controlled infusion is consistent across subgroups within the population. CONCLUSIONS: Our study shows that adaptive target-controlled infusion has the potential to become a practical tool for patient-tailored antibiotic dosing in the intensive care unit.

来源:Clin Pharmacokinet,查看原文。版权归原作者所有。

引用

  1. Colin PJ, Jonckheere S, Struys MMRF, et al. Target-Controlled Continuous Infusion for Antibiotic Dosing: Proof-of-Principle in an In-silico Vancomycin Trial in Intensive Care Unit Patients. Clin Pharmacokinet. 2018. PMID: 29512049. doi:10.1007/s40262-018-0643-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。